Arvinas (ARVN) Asset Utilization Ratio (2018 - 2026)
Arvinas (ARVN) recorded quarterly Asset Utilization Ratio of 0.13 in Q1 2026, down 61.05% quarter-over-quarter from 0.34 in Q4 2025, and down 67.91% on a YoY basis from 0.41 in Q1 2025.
Arvinas (ARVN) Asset Utilization Ratio (2018 - 2026) Analysis & Trends
Arvinas' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.13 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 67.91% year-over-year to 0.13; the TTM figure through Mar 2026 stood at 0.13 (down 67.91% YoY), while the FY2025 annual figure was 0.29, up 32.02% from the prior year.
- Asset Utilization Ratio was 0.13 for Q1 2026 at Arvinas, down from 0.34 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.41 in Q1 2025 to a low of 0.05 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.17 across 5 years, with a median of 0.13 in 2026.
- The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio soared 620.26% in 2025, then plunged 67.91% in 2026.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.1 in 2022, then sank by 34.12% to 0.07 in 2023, then surged by 251.05% to 0.23 in 2024, then surged by 44.13% to 0.34 in 2025, then plunged by 61.05% to 0.13 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.13 (Q1 2026), 0.34 (Q4 2025), and 0.36 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | 0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | 0.34 |
| Sep 30, 2025 | 0.36 |
| Jun 30, 2025 | 0.39 |
| Mar 31, 2025 | 0.41 |
| Dec 31, 2024 | 0.23 |
| Sep 30, 2024 | 0.13 |
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | 0.07 |
| Sep 30, 2023 | 0.15 |
| Jun 30, 2023 | 0.14 |
| Mar 31, 2023 | 0.11 |
| Dec 31, 2022 | 0.10 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | 0.07 |
| Mar 31, 2022 | 0.05 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.02 |
| Jun 30, 2021 | 0.04 |